
11 - 50 employees
💊 Pharmaceuticals
🧬 Biotechnology
Pharmaceuticals • Biotechnology
Egetis is an innovative, integrated pharmaceutical company focused on late-stage development and commercialization of treatments for serious diseases with significant unmet medical needs, particularly in the orphan drug segment. The company's lead product candidate is Emcitate (tiratricol) for MCT8 deficiency/Allan‑Herndon‑Dudley syndrome; its pipeline also includes Aladote for acetaminophen (paracetamol) overdose. Headquartered in Stockholm, Sweden, Egetis positions itself around development, regulatory interaction and market access for rare-disease therapeutics.
📡 We watch Egetis Therapeutics's careers page
Several times a day
how often we check
0
roles posted in the last 30 days
1
roles closed in the last year
Selected: 🆕 Date Added.
🕒 September 18
Clinical development director leading medical oversight and study strategy for Egetis Therapeutics’ rare-disease drug programs. Guiding safety, data interpretation, regulatory documentation, and cross-functional trial execution.
🕒 September 5
Field-based Regional Medical Director advancing Egetis Therapeutics’ rare-disease therapy launches. Leading scientific exchange, clinical-trial support, and pediatric specialist engagement.